Enright, J.M.; Zhang, S.; Thebeau, C.; Siebert, E.; Jin, A.; Gadiraju, V.; Zhang, X.; Chen, S.; Semenkovich, C.F.; Rajagopal, R.
Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression. J. Clin. Med. 2021, 10, 126.
https://doi.org/10.3390/jcm10010126
AMA Style
Enright JM, Zhang S, Thebeau C, Siebert E, Jin A, Gadiraju V, Zhang X, Chen S, Semenkovich CF, Rajagopal R.
Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression. Journal of Clinical Medicine. 2021; 10(1):126.
https://doi.org/10.3390/jcm10010126
Chicago/Turabian Style
Enright, Jennifer M., Sheng Zhang, Christina Thebeau, Emily Siebert, Alexander Jin, Veda Gadiraju, Xiaodong Zhang, Shiming Chen, Clay F. Semenkovich, and Rithwick Rajagopal.
2021. "Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression" Journal of Clinical Medicine 10, no. 1: 126.
https://doi.org/10.3390/jcm10010126
APA Style
Enright, J. M., Zhang, S., Thebeau, C., Siebert, E., Jin, A., Gadiraju, V., Zhang, X., Chen, S., Semenkovich, C. F., & Rajagopal, R.
(2021). Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression. Journal of Clinical Medicine, 10(1), 126.
https://doi.org/10.3390/jcm10010126